Increased HCN channel driven inward rectification in benign cramp fasciculation syndrome

Brain

Volumn 138, Issue 11, 2015, Pages 3168-3179

  Czesnik, Dirk ^a   Howells, James ^b   Negro, Francesco ^c   Wagenknecht, Melanie ^a   Hanner, Susanne ^a   Farina, Dario ^c   Burke, David ^b   Paulus, Walter ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF SYDNEY   (Australia)

^c BERNSTEIN CENTER FOR COMPUTATIONAL NEUROSCIENCE   (Germany)

Author keywords

HCN channels; Ih; multi unit EMG; muscle cramps; threshold tracking

Indexed keywords

HYPERPOLARIZATION ACTIVATED CYCLIC NUCLEOTIDE GATED CHANNEL;

ADULT; AGED; ARTICLE; BENIGN CRAMP FASCICULATION SYNDROME; CLINICAL ARTICLE; CONDITIONING; CONTROLLED STUDY; ELECTRIC CONDUCTANCE; ELECTRIC POTENTIAL; ELECTROMYOGRAPHY; FASCICULATION; FEMALE; HUMAN; HYPERPOLARIZATION; MALE; MATHEMATICAL MODEL; MEDIAN NERVE; MOTOR NERVE; MOTOR NERVE CONDUCTION; MOTOR UNIT; MUSCLE CRAMP; NERVE CELL MEMBRANE STEADY POTENTIAL; NERVE EXCITABILITY; POSTERIOR TIBIAL NERVE; PRIORITY JOURNAL; REFRACTORY PERIOD; ACTION POTENTIAL; CASE CONTROL STUDY; MEMBRANE POTENTIAL; METABOLISM; MIDDLE AGED; MOTONEURON; MUSCLE CONTRACTION; NERVE FIBER; NEUROMUSCULAR DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ACTION POTENTIALS; ADULT; AGED; AXONS; CASE-CONTROL STUDIES; ELECTROMYOGRAPHY; FEMALE; HUMANS; HYPERPOLARIZATION-ACTIVATED CYCLIC NUCLEOTIDE-GATED CHANNELS; MALE; MEMBRANE POTENTIALS; MIDDLE AGED; MOTOR NEURONS; MUSCLE CONTRACTION; MUSCLE CRAMP; NEUROMUSCULAR DISEASES; YOUNG ADULT;

EID: 84947742544     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awv254     Document Type: Article

References (51)

1. Ahmed A, Simmons Z. Isaacs syndrome: a review. Muscle Nerve 2015; 52: 5-12.
2. Biel M, Wahl-Schott C, Michalakis S, Zong X. Hyperpolarizationactivated cation channels: from genes to function. Physiol Rev 2009; 89: 8475.
3. Boerio D, Bostock H, Spescha R, Z'Graggen WJ. Potassium and the excitability properties of normal human motor axons in vivo. PLoS One 2014; 9: e98262.
4. Bostock H. The strength-duration relationship for excitation of myelinated nerve: computed dependence on membrane parameters. J Physiol 1983; 341: 59-74.
5. Bostock H, Baker M, Reid G. Changes in excitability of human motor axons underlying post-ischaemic fasciculations: evidence for two stable states. J Physiol 1991; 441: 537-57.
6. Bostock H, Cikurel K, Burke D. Threshold tracking techniques in the study of human peripheral nerve. Muscle Nerve 1998; 21: 137-58.
7. Bugiardini E, Rivolta I, Binda A, Soriano Caminero A, Cirillo F, Cinti A, et al. SCN4A mutation as modifying factor of Myotonic Dystrophy Type 2 phenotype. Neuromuscul Disord 2015; 24: 301-7. doi: 10. 1016/j. nmd. 2015. 01. 006.
8. Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neurophysiol 2001; 112: 1575-85.
9. Caress JB, Walker FO. The spectrum of ectopic motor nerve behavior: from fasciculations to neuromyotonia. Neurologist 2002; 8: 41-6.
10. Dewarrat A, Kuntzer T, Regli F. Muscle cramps: mechanism, etiology and current treatment. Schweiz Rundsch Med Prax 1994; 83: 444-8.
11. Fan Y, Fricker D, Brager DH, Chen X, Lu H-C, Chitwood RA, et al. Activity-dependent decrease of excitability in rat hippocampal neurons through increases in Ih. Nature Neurosci 2005; 8: 1542-52.
12. Holobar A, Zazula D. Correlation-based decomposition of surface electromyograms at low contraction forces. Med Biol Eng Comput 2004; 42: 487-95.
13. Holobar A, Minetto MA, Botter A, Negro F, Farina D. Experimental analysis of accuracy in the identification of motor unit spike trains from high-density surface EMG. IEEE Trans Neural Rehabil Eng 2010; 18: 221-9.
14. Holobar A, Minetto MA, Farina D. Accurate identification of motor unit discharge patterns from high-density surface EMG and validation with a novel signal-based performance metric. J Neural Eng 2014; 11: 016008.
15. Horn S, Quasthoff S, Grafe P, Bostock H, Renner R, Schrank B. Abnormal axonal inward rectification in diabetic neuropathy. Muscle Nerve 1996; 19:1268-75.
16. Howells J, Trevillion L, Bostock H, Burke D. The voltage dependence of Ih in human myelinated axons. J Physiol 2012; 590: 1625-40.
17. Howells J, Czesnik D, Trevillion L, Burke D. Excitability and the safety margin in human axons during hyperthermia. J Physiol 2013; 591: 3063-80.
18. Jankelowitz SK, Howells J, Burke D. Plasticity of inwardly rectifying conductances following a corticospinal lesion in human subjects. J Physiol 2007; 581: 927-40.
19. Kanai K, Kuwabara S, Arai K Sung J-Y, Ogawara K, Hattori T. Muscle cramp in Machado-Joseph disease: altered motor axonal excitability properties and mexiletine treatment. Brain 2003; 126: 965-73
20. Kanai K, Kuwabara S, Misawa S, Tamura N, Ogawara K, Nakata M, et al. Altered axonal excitability properties in amyotrophic lateral sclerosis: impaired potassium channel function related to disease stage. Brain 2006; 129: 953-62.
21. Katzberg HD. Neurogenic muscle cramps. J Neurol 2015; 262: 1814-21.
22. Kiernan MC, Bostock H. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons. Brain 2000; 123: 2542-51.
23. Kiernan MC, Burke D, Andersen KV, Bostock H. Multiple measures of axonal excitability: a new approach in clinical testing. Muscle Nerve 2000; 23: 399-409.
24. Kiernan MC, Hart IK, Bostock H. Excitability properties of motor axons in patients with spontaneous motor unit activity. J Neurol Neurosurg Psychiatry 2001a; 70: 56-64.
25. Kiernan MC, Isbister GK, Lin C.S.-Y, Burke D, Bostock H. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish. Ann Neurol 2005; 57: 339-48.
26. Kiernan MC, Lin C.S.-Y, Andersen KV, Murray NM, Bostock H. Clinical evaluation of excitability measures in sensory nerve. Muscle Nerve 2001b; 24: 883-92.
27. Kiernan MC, Lin CS, Burke D. Differences in activity-dependent hyperpolarization in human sensory and motor axons. J Physiol 2004; 558: 341-49.
28. Kortman HG, Veldink JH, Drost G. Positive muscle phenomena-diagnosis, pathogenesis and associated disorders. Nat Rev Neurol 2012; 8: 97-107.
29. Krarup C, Moldovan M. Nerve conduction and excitability studies in peripheral nerve disorders. Curr Opin Neurol 2009; 22: 460-6.
30. Krishnan AV, Lin C.S.-Y, Park SB, Kiernan MC. Axonal ion channels from bench to bedside: a translational neuroscience perspective. Prog Neurobiol 2009; 89: 288-313.
31. Lin C.S.-Y, Krishnan AV, Lee MJ, Zagami AS, You HL, Yang CC, et al. Nerve function and dysfunction in acute intermittent porphyria. Brain 2008; 131: 2510-19.
32. Maddison P, Newsom-Davis J, Mills KR. Strength-duration properties of peripheral nerve in aquired neuromytonia. Muscle Nerve 1999; 22: 823-30.
33. Marateb HR, McGill KC, Holobar A, Lateva ZC, Mansourian M, Merletti R. Accuracy assessment of CKC high-density surface EMG decomposition in biceps femoris muscle. J Neural Eng 2011; 8: 066002.
34. Miller TM and Layzer RB. Muscle cramps. Muscle Nerve 2005; 32: 431-42.
35. Minetto MA, Holobar A, Botter A, Ravenni R, Farina D. Mechanisms of cramp contractions:peripheral or central generation? J Physiol 2011; 589: 5759-73.
36. Mogyoros I, Kiernan MC, Burke D. Strength-duration properties of human peripheral nerve. Brain 1996; 119: 439-47.
37. Nodera H, Kaji R. Nerve excitability testing and its clinical application to neuromuscular diseases. Clin Neurophysiol 2006; 117: 1902-16.
38. Pape HC. Queer current and pacemaker: The hyperpolarizationactivated cation current in neurons. Annu Rev Physiol 1996; 58: 299-327.
39. Park SB, Lin CS, Krishnan AV, Simon NG, Bostock H, Vincent A, et al. Axonal dysfunction with voltage gated potassium channel complex antibodies. Exp Neurol 2014; 261: 337-42.
40. Pian P, Bucchi A, Decostanzo A, Robinson RB, Siegelbaum SA. Modulation of cyclic nucleotide-regulated HCN channels by PIP(2) and receptors coupled to phospholipase C. Pflugers Arch 2007; 455: 125-45.
41. Robinson RB, Siegelbaum SA. Hyperpolarization-activated cation currents: from molecules to physiological function. Ann Rev Physiol 2003; 65: 453-80.
42. Shah MM. Cortical HCN channels: function, trafficking and plasticity. J Physiol 2014; 592: 2711-9.
43. Shibuta Y, Nodera H, Mori A, Okita T, Kaji R. Peripheral nerve excitability measures at different target levels: The effects of aging and diabetic neuropathy. J Clin Neurophysiol 2010; 27: 350-7.
44. Shimatani Y, Nodera H, Shibuta Y, Miyazaki Y, Misawa S, Kuwabara S, et al. Abnormal gating of axonal slow potassium current in cramp-fasciculation syndrome. Clin Neurophysiol 2015a; 126: 1246-54. Doi: 10. 1016/j. clinph. 2004. 09. 013 Epub ahead of print
45. Shimatani Y, Nodera H, Osaki Y, Banzrai C, Takayasu K, Endo S, et al. Upregulation of axonal HCN current by methylglyoxal: Potential association with diabetic polyneuropathy. Clin Neurophysiol 2015b. pii:S1388-2457(15)00165-0.
46. Tomlinson S, Burke D, Hanna M, Koltzenburg M, Bostock H. In vivo assessment of HCN channel current (I(h)) in human motor axons. Muscle Nerve 2010; 41: 247-56.
47. Trevillion L, Howells J, Bostock H, Burke D. Properties of low-threshold motor axons in the human median nerve. J Physiol 2010; 588: 2503-15.
48. Vagg R, Mogyoros I, Kiernan MC, Burke D. Activity-dependent hyperpolarization of human motor axons produced by natural activity. J Physiol 1998; 507: 919-25.
49. Vucic S, Kiernan MC. Axonal excitability properties in amyotrophic lateral sclerosis. Clin Neurophysiol 2006; 117: 1458-66.
50. Weiss G. Sur la possibilite de rendre comparables entre eux les appareils servant a l'excitation electrique. Arch Ital Biol 1901; 35: 413-46.
51. Zimlichman R, Krauss S, Paran E. Muscle cramps induced by b-blockers with intrinsic sympathomimetic acitivity properties: a hint of a possible mechanism. Arch Intern Med 1991; 151: 1021.